[
  {
    "ts": null,
    "headline": "Here's What Key Metrics Tell Us About Moderna (MRNA) Q2 Earnings",
    "summary": "Although the revenue and EPS for Moderna (MRNA) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
    "url": "https://finnhub.io/api/news?id=5e0677e2190e5b8fc88126bf041d9e98bda7e4860e258bfc8ad5ab85daf66a48",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754085602,
      "headline": "Here's What Key Metrics Tell Us About Moderna (MRNA) Q2 Earnings",
      "id": 136183901,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Although the revenue and EPS for Moderna (MRNA) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
      "url": "https://finnhub.io/api/news?id=5e0677e2190e5b8fc88126bf041d9e98bda7e4860e258bfc8ad5ab85daf66a48"
    }
  },
  {
    "ts": null,
    "headline": "Equities, Yields Tumble Following Jobs Report Shock; Wall Street Posts Weekly Declines",
    "summary": "US equities and Treasury yields declined Friday following a weaker-than-expected jobs report and the",
    "url": "https://finnhub.io/api/news?id=8032be3437c08763352826aff3557ce25cb6f2bf31b7854bbf608fc291aed19e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754082918,
      "headline": "Equities, Yields Tumble Following Jobs Report Shock; Wall Street Posts Weekly Declines",
      "id": 136183000,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "US equities and Treasury yields declined Friday following a weaker-than-expected jobs report and the",
      "url": "https://finnhub.io/api/news?id=8032be3437c08763352826aff3557ce25cb6f2bf31b7854bbf608fc291aed19e"
    }
  },
  {
    "ts": null,
    "headline": "Stock Losses Extend on Tariffs, Swiss Franc Drops: Markets Wrap",
    "summary": "(Bloomberg) -- A global stock selloff extended to a sixth day - the longest losing streak since September 2023 - as President Donald Trump boosted tariffs across the world and two days of solid megacap tech earnings failed to lift sentiment.Most Read from BloombergThe World’s Data Center Capital Has Residents SurroundedAn Abandoned Art-Deco Landmark in Buffalo Awaits RevivalWe Should All Be Biking Along the BeachBudapest’s Most Historic Site Gets a Controversial RebuildSan Francisco in Talks Wit",
    "url": "https://finnhub.io/api/news?id=8999e4b029e23177973986e041c5070c8ff614e9174833075963d538a9ba9015",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754027870,
      "headline": "Stock Losses Extend on Tariffs, Swiss Franc Drops: Markets Wrap",
      "id": 136160730,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "(Bloomberg) -- A global stock selloff extended to a sixth day - the longest losing streak since September 2023 - as President Donald Trump boosted tariffs across the world and two days of solid megacap tech earnings failed to lift sentiment.Most Read from BloombergThe World’s Data Center Capital Has Residents SurroundedAn Abandoned Art-Deco Landmark in Buffalo Awaits RevivalWe Should All Be Biking Along the BeachBudapest’s Most Historic Site Gets a Controversial RebuildSan Francisco in Talks Wit",
      "url": "https://finnhub.io/api/news?id=8999e4b029e23177973986e041c5070c8ff614e9174833075963d538a9ba9015"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Cuts Forecast, Stock Wobbles Despite Beat",
    "summary": "UK shipment delay trims revenue; cost cuts cushion impact",
    "url": "https://finnhub.io/api/news?id=9d671c64b655f8da3fbfd2b6116197c119115dec7499c9c00de08c283bb6f2ab",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754079012,
      "headline": "Moderna Cuts Forecast, Stock Wobbles Despite Beat",
      "id": 136183904,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "UK shipment delay trims revenue; cost cuts cushion impact",
      "url": "https://finnhub.io/api/news?id=9d671c64b655f8da3fbfd2b6116197c119115dec7499c9c00de08c283bb6f2ab"
    }
  },
  {
    "ts": null,
    "headline": "What Companies Have Said About Jobs in the Past Quarter",
    "summary": "On Thursday, Moderna executives said the biotech company would reduce its headcount by the end of the year to under 5,000, down from 5,800 at the beginning of this year.  In July, Microsoft said it is cutting 9,000 jobs, or about 4% of its global workforce, in its latest round of layoffs.  Most of the layoffs, which began in the first few weeks of the current quarter, targeted middle management, the company said.",
    "url": "https://finnhub.io/api/news?id=3782ac51316c0cbc52fed79e4537d56561c1d1a920a91a4b50fc16a957b00c29",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754077678,
      "headline": "What Companies Have Said About Jobs in the Past Quarter",
      "id": 136183209,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "On Thursday, Moderna executives said the biotech company would reduce its headcount by the end of the year to under 5,000, down from 5,800 at the beginning of this year.  In July, Microsoft said it is cutting 9,000 jobs, or about 4% of its global workforce, in its latest round of layoffs.  Most of the layoffs, which began in the first few weeks of the current quarter, targeted middle management, the company said.",
      "url": "https://finnhub.io/api/news?id=3782ac51316c0cbc52fed79e4537d56561c1d1a920a91a4b50fc16a957b00c29"
    }
  },
  {
    "ts": null,
    "headline": "Moderna sharpens focus on $1.5bn cost cutting plan after 41% revenue slump",
    "summary": "Analysts call the revenue drop driven by dipping Covid vaccine sales ‘unsurprising’.",
    "url": "https://finnhub.io/api/news?id=da7495941c21b40ddc316969dbfb87808d63c9b046416855bdbe38b97c1e02e7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754072098,
      "headline": "Moderna sharpens focus on $1.5bn cost cutting plan after 41% revenue slump",
      "id": 136183906,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Analysts call the revenue drop driven by dipping Covid vaccine sales ‘unsurprising’.",
      "url": "https://finnhub.io/api/news?id=da7495941c21b40ddc316969dbfb87808d63c9b046416855bdbe38b97c1e02e7"
    }
  },
  {
    "ts": null,
    "headline": "MRNA Beats on Q2 Earnings & Sales, Stock Down on Lowered Sales View",
    "summary": "MRNA tops Q2 estimates with a narrower loss and revenue beat, but the stock slips after trimming 2025 sales guidance.",
    "url": "https://finnhub.io/api/news?id=3a49c8107c123b7e307fa0aa7ceac15cabef1164d8a32652eaaac694eca1fee5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754068860,
      "headline": "MRNA Beats on Q2 Earnings & Sales, Stock Down on Lowered Sales View",
      "id": 136183324,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "MRNA tops Q2 estimates with a narrower loss and revenue beat, but the stock slips after trimming 2025 sales guidance.",
      "url": "https://finnhub.io/api/news?id=3a49c8107c123b7e307fa0aa7ceac15cabef1164d8a32652eaaac694eca1fee5"
    }
  },
  {
    "ts": null,
    "headline": "Why Moderna (MRNA) Stock Is Trading Lower Today",
    "summary": "Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 7.1% in the afternoon session after the company trimmed the upper end of its 2025 revenue forecast, citing a delay in vaccine shipments. The company pointed to a delay in vaccine deliveries to the United Kingdom, which it pushed into the first quarter of 2026. This news overshadowed second-quarter results that beat Wall Street expectations. For the quarter, Moderna's revenue dropped about 41% from the previous year to $142 million, drive",
    "url": "https://finnhub.io/api/news?id=f4ea637a6319108d3c58eda30bbe0c6ea6a3766a8d106ebebce53102a680ec8a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754065259,
      "headline": "Why Moderna (MRNA) Stock Is Trading Lower Today",
      "id": 136183908,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 7.1% in the afternoon session after the company trimmed the upper end of its 2025 revenue forecast, citing a delay in vaccine shipments. The company pointed to a delay in vaccine deliveries to the United Kingdom, which it pushed into the first quarter of 2026. This news overshadowed second-quarter results that beat Wall Street expectations. For the quarter, Moderna's revenue dropped about 41% from the previous year to $142 million, drive",
      "url": "https://finnhub.io/api/news?id=f4ea637a6319108d3c58eda30bbe0c6ea6a3766a8d106ebebce53102a680ec8a"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Tempers High End of Revenue Guidance Amid Vaccine Delivery Timing Shift",
    "summary": "Moderna (MRNA) on Friday lowered the top end of its 2025 revenue guidance range due to a delay in CO",
    "url": "https://finnhub.io/api/news?id=f62c129327910fed847fe651aff500a651c212316c018a7dcb8517b69427d647",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754064637,
      "headline": "Moderna Tempers High End of Revenue Guidance Amid Vaccine Delivery Timing Shift",
      "id": 136183909,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna (MRNA) on Friday lowered the top end of its 2025 revenue guidance range due to a delay in CO",
      "url": "https://finnhub.io/api/news?id=f62c129327910fed847fe651aff500a651c212316c018a7dcb8517b69427d647"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Stock Is Falling After Earnings. What Has Wall Street Worried.",
    "summary": "The biotech company reported second-quarter financial results on Friday ahead of market open, a day after announcing plans to cut 10% of its staff.",
    "url": "https://finnhub.io/api/news?id=74a9d1f211c4252a3299035be4344fd0b45cc7e277ebd9777093ea27801a0680",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754058780,
      "headline": "Moderna Stock Is Falling After Earnings. What Has Wall Street Worried.",
      "id": 136183910,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The biotech company reported second-quarter financial results on Friday ahead of market open, a day after announcing plans to cut 10% of its staff.",
      "url": "https://finnhub.io/api/news?id=74a9d1f211c4252a3299035be4344fd0b45cc7e277ebd9777093ea27801a0680"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Stock Drops as Firm Cuts Revenue Outlook on UK Vaccine Deliveries Delay",
    "summary": "Shares of Moderna fell sharply Friday after the company lowered the top end of its full-year revenue outlook because of a delay in vaccine deliveries to the UK.",
    "url": "https://finnhub.io/api/news?id=a640c6088d78d8978ca9ed05429f1288d74ca4d2e31256d2543aeebcfe260373",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754058604,
      "headline": "Moderna Stock Drops as Firm Cuts Revenue Outlook on UK Vaccine Deliveries Delay",
      "id": 136183911,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Shares of Moderna fell sharply Friday after the company lowered the top end of its full-year revenue outlook because of a delay in vaccine deliveries to the UK.",
      "url": "https://finnhub.io/api/news?id=a640c6088d78d8978ca9ed05429f1288d74ca4d2e31256d2543aeebcfe260373"
    }
  },
  {
    "ts": null,
    "headline": "Stocks Slump on Tariffs and Weak US Job Growth",
    "summary": "The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures...",
    "url": "https://finnhub.io/api/news?id=d0b5022825f76d5d648cea23db874fa76af76372001e1c23b4f4f8535494e264",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754057412,
      "headline": "Stocks Slump on Tariffs and Weak US Job Growth",
      "id": 136164945,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures...",
      "url": "https://finnhub.io/api/news?id=d0b5022825f76d5d648cea23db874fa76af76372001e1c23b4f4f8535494e264"
    }
  },
  {
    "ts": null,
    "headline": "Coinbase, ExxonMobil & Chevron, Moderna: Trending Tickers",
    "summary": "Coinbase (COIN) shares are under pressure after a drop in adjusted profit, with sluggish retail crypto trading volumes despite rising crypto prices. ExxonMobil (XOM) and Chevron (CVX) reported steep profit declines in the second quarter, though both topped revenue expectations as oil production hit record levels. Moderna (MRNA) reported a smaller loss than expected in Q2 but lowered the high-end of its full-year revenue outlook amid shipment delays to the UK. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
    "url": "https://finnhub.io/api/news?id=48c6dc65dd29f6eb79745eb64243f2b64943e8f4239d97a5dbdb650a70f88292",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754055960,
      "headline": "Coinbase, ExxonMobil & Chevron, Moderna: Trending Tickers",
      "id": 136165230,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Coinbase (COIN) shares are under pressure after a drop in adjusted profit, with sluggish retail crypto trading volumes despite rising crypto prices. ExxonMobil (XOM) and Chevron (CVX) reported steep profit declines in the second quarter, though both topped revenue expectations as oil production hit record levels. Moderna (MRNA) reported a smaller loss than expected in Q2 but lowered the high-end of its full-year revenue outlook amid shipment delays to the UK. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
      "url": "https://finnhub.io/api/news?id=48c6dc65dd29f6eb79745eb64243f2b64943e8f4239d97a5dbdb650a70f88292"
    }
  },
  {
    "ts": null,
    "headline": "Moderna's Key Patent Win Overshadowed By Gloomy Outlook",
    "summary": "Moderna Inc. (NASDAQ:MRNA) reported on Friday a second-quarter loss of $2.13 per share, beating the consensus of a $2.98 loss, an improvement from a loss of $3.33 a year ago. The COVID-19 vaccine maker reported quarterly sales of $142 million, beating the consensus of $116.34 million. Sales fell 41% from $241 million in the same period in 2024. The decline was primarily driven by lower COVID-19 vaccine sales, which totaled $114 million in the quarter. Also Read: Robert Kennedy Jr Blasts Vaccine",
    "url": "https://finnhub.io/api/news?id=212fa4f3d46b9e154a74420c485eefe25fcc53dce03633dfcea5fb8e55225e1f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754052295,
      "headline": "Moderna's Key Patent Win Overshadowed By Gloomy Outlook",
      "id": 136165497,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna Inc. (NASDAQ:MRNA) reported on Friday a second-quarter loss of $2.13 per share, beating the consensus of a $2.98 loss, an improvement from a loss of $3.33 a year ago. The COVID-19 vaccine maker reported quarterly sales of $142 million, beating the consensus of $116.34 million. Sales fell 41% from $241 million in the same period in 2024. The decline was primarily driven by lower COVID-19 vaccine sales, which totaled $114 million in the quarter. Also Read: Robert Kennedy Jr Blasts Vaccine",
      "url": "https://finnhub.io/api/news?id=212fa4f3d46b9e154a74420c485eefe25fcc53dce03633dfcea5fb8e55225e1f"
    }
  },
  {
    "ts": null,
    "headline": "Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday Amid Revived Trade War Fears",
    "summary": "The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.8% and the actively tr",
    "url": "https://finnhub.io/api/news?id=bad25a2ed5f7f4ff610194dc76409ba7f1c1655952c6d227e8736d1385811956",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754050723,
      "headline": "Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday Amid Revived Trade War Fears",
      "id": 136165733,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.8% and the actively tr",
      "url": "https://finnhub.io/api/news?id=bad25a2ed5f7f4ff610194dc76409ba7f1c1655952c6d227e8736d1385811956"
    }
  },
  {
    "ts": null,
    "headline": "Moderna (MRNA) Reports Q2 Loss, Beats Revenue Estimates",
    "summary": "Moderna (MRNA) delivered earnings and revenue surprises of +28.76% and +11.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=9a93211dec14a15c6b0d658a81b1798a18aba8ddb3adcaa2610e37620b6041fa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754050201,
      "headline": "Moderna (MRNA) Reports Q2 Loss, Beats Revenue Estimates",
      "id": 136166552,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna (MRNA) delivered earnings and revenue surprises of +28.76% and +11.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=9a93211dec14a15c6b0d658a81b1798a18aba8ddb3adcaa2610e37620b6041fa"
    }
  },
  {
    "ts": null,
    "headline": "Moderna, Inc. (MRNA) Q2 2025 Earnings Call Transcript",
    "summary": "Moderna, Inc. (NASDAQ:MRNA) Q2 2025 Earnings Conference Call August 1, 2025 8:00 AM ETCompany ParticipantsJames M.",
    "url": "https://finnhub.io/api/news?id=a956bbbb37dd25fbf69d6ae761a697014fc70fd592b02d58c67c2addbc641ba1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754049392,
      "headline": "Moderna, Inc. (MRNA) Q2 2025 Earnings Call Transcript",
      "id": 136166352,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "Moderna, Inc. (NASDAQ:MRNA) Q2 2025 Earnings Conference Call August 1, 2025 8:00 AM ETCompany ParticipantsJames M.",
      "url": "https://finnhub.io/api/news?id=a956bbbb37dd25fbf69d6ae761a697014fc70fd592b02d58c67c2addbc641ba1"
    }
  },
  {
    "ts": null,
    "headline": "Moderna, Inc. 2025 Q2 - Results - Earnings Call Presentation",
    "summary": "The following slide deck was published by Moderna, Inc.",
    "url": "https://finnhub.io/api/news?id=9b8534240388d663a7e583465434d22a789cb5bf8ea3c80c0680429807241353",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754049318,
      "headline": "Moderna, Inc. 2025 Q2 - Results - Earnings Call Presentation",
      "id": 136165975,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "The following slide deck was published by Moderna, Inc.",
      "url": "https://finnhub.io/api/news?id=9b8534240388d663a7e583465434d22a789cb5bf8ea3c80c0680429807241353"
    }
  },
  {
    "ts": null,
    "headline": "Moderna lowers top end of revenue guidance as vaccine group targets cost cuts",
    "summary": "Investing.com - Moderna has lowered the top end of its full-year revenue forecast, citing a delay in the timing of deliveries of its COVID-19 jab to the United Kingdom, presenting a fresh setback for a company already aiming to slash expenses and boost recently tepid demand.",
    "url": "https://finnhub.io/api/news?id=d536976f31ad9dc456c5fb0c4bd1adc26f72ddaad64a086a76f073128141bc5c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754048764,
      "headline": "Moderna lowers top end of revenue guidance as vaccine group targets cost cuts",
      "id": 136183917,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Investing.com - Moderna has lowered the top end of its full-year revenue forecast, citing a delay in the timing of deliveries of its COVID-19 jab to the United Kingdom, presenting a fresh setback for a company already aiming to slash expenses and boost recently tepid demand.",
      "url": "https://finnhub.io/api/news?id=d536976f31ad9dc456c5fb0c4bd1adc26f72ddaad64a086a76f073128141bc5c"
    }
  },
  {
    "ts": null,
    "headline": "Stocks Fall Pre-Bell as Trump Announces New Tariffs; Traders Await Key Jobs Report",
    "summary": "The benchmark US stock measures fell before Friday's open after President Donald Trump announced swe",
    "url": "https://finnhub.io/api/news?id=eb09a1001e11c20cd51a6b0715044c3c3e81a72a0a1914f439d9c474f8b98433",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754048272,
      "headline": "Stocks Fall Pre-Bell as Trump Announces New Tariffs; Traders Await Key Jobs Report",
      "id": 136165238,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The benchmark US stock measures fell before Friday's open after President Donald Trump announced swe",
      "url": "https://finnhub.io/api/news?id=eb09a1001e11c20cd51a6b0715044c3c3e81a72a0a1914f439d9c474f8b98433"
    }
  },
  {
    "ts": null,
    "headline": "Moderna (NASDAQ:MRNA) Exceeds Q2 Expectations But Stock Drops",
    "summary": "Biotechnology company Moderna (NASDAQ:MRNA) reported Q2 CY2025 results exceeding the market’s revenue expectations, but sales fell by 41.1% year on year to $142 million. On the other hand, the company’s full-year revenue guidance of $1.85 billion at the midpoint came in 10.6% below analysts’ estimates. Its GAAP loss of $2.13 per share was 29.8% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=73f639b266fc489f9926e90dfbb4ef294c4b514fcb36b010440d4c9a21283a9f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754047690,
      "headline": "Moderna (NASDAQ:MRNA) Exceeds Q2 Expectations But Stock Drops",
      "id": 136183919,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Biotechnology company Moderna (NASDAQ:MRNA) reported Q2 CY2025 results exceeding the market’s revenue expectations, but sales fell by 41.1% year on year to $142 million. On the other hand, the company’s full-year revenue guidance of $1.85 billion at the midpoint came in 10.6% below analysts’ estimates. Its GAAP loss of $2.13 per share was 29.8% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=73f639b266fc489f9926e90dfbb4ef294c4b514fcb36b010440d4c9a21283a9f"
    }
  }
]